Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025)
Benitec Biopharma (BNTC) posted Non Operating Income of $1.5 million for Q4 2025, up 83.77% sequentially from $838000.0 in Q3 2025, and up 22.91% YoY from $1.3 million in Q4 2024.
Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Non Operating Income for 7 years, with the latest figure at $1.5 million in Q4 2025.
- Quarterly Non Operating Income rose 22.91% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 42.84% YoY) and the FY2025 annual result came in at $3.8 million, up 325.66% from the prior year.
- Non Operating Income improved to $1.5 million in Q4 2025 per BNTC's latest filing, from $838000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.5 million in Q4 2025 and troughed at -$329000.0 in Q2 2022.
- A 5-year average of $347850.0 and a median of $130500.0 in 2021 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2021 and 2025: Non Operating Income slumped 1388.89% in 2021, then soared 20950.0% in 2025.
- Over 5 years, Non Operating Income stood at $14000.0 in 2021, then jumped by 1321.43% to $199000.0 in 2022, then tumbled by 35.18% to $129000.0 in 2023, then soared by 871.32% to $1.3 million in 2024, then rose by 22.91% to $1.5 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered $1.5 million, $838000.0, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 732,000.00 |
| Jun 30, 2024 | 993,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | -80,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | 199,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -329,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | -223,000.00 |
| Jun 30, 2021 | 132,000.00 |
| Mar 31, 2021 | -116,000.00 |